2024 |
LyondellBasell Industries NV - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2024 |
Nabors Industries Ltd
|
Independent Director |
- |
- |
2024 |
Cullen Frost Bankers Inc.
|
Independent Director |
- |
- |
2024 |
Par Pacific Holdings Inc
|
Independent Director |
- |
- |
2023 |
Nabors Industries Ltd
|
Independent Director |
550 K |
0.0 % |
2023 |
LyondellBasell Industries NV - Ordinary Shares - Class A
|
Independent Director |
331.8 K |
0.8 % |
2023 |
Par Pacific Holdings Inc
|
Independent Director |
205 K |
- |
2023 |
Cullen Frost Bankers Inc.
|
Independent Director |
- |
- |
2022 |
Nabors Industries Ltd
|
Independent Director |
550 K |
1.9 % |
2022 |
LyondellBasell Industries NV - Ordinary Shares - Class A
|
Independent Director |
329.2 K |
26.7 % |
2022 |
Cullen Frost Bankers Inc.
|
Independent Director |
176.1 K |
17.3 % |
2022 |
Par Pacific Holdings Inc
|
Independent Director |
- |
- |
2021 |
Nabors Industries Ltd
|
Independent Director |
540 K |
81.8 % |
2021 |
LyondellBasell Industries NV - Ordinary Shares - Class A
|
Independent Director |
259.8 K |
- |
2021 |
Cullen Frost Bankers Inc.
|
Independent Director |
150.1 K |
9.8 % |
2021 |
Par Pacific Holdings Inc
|
Independent Director |
40 K |
- |
2020 |
Nabors Industries Ltd
|
Independent Director |
297.1 K |
-15.8 % |
2020 |
Cullen Frost Bankers Inc.
|
Independent Director |
136.8 K |
- |
2020 |
LyondellBasell Industries NV - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2019 |
Nabors Industries Ltd
|
Independent Director |
353 K |
- |
2019 |
Cullen Frost Bankers Inc.
|
Independent Director |
- |
- |
2018 |
Nabors Industries Ltd
|
Director |
- |
- |
2015 |
Sarepta Therapeutics Inc
|
- |
197.9 K |
-50.5 % |
2014 |
Sarepta Therapeutics Inc
|
Independent Director |
400.1 K |
-27.3 % |
2013 |
Sarepta Therapeutics Inc
|
Independent Director |
550.4 K |
507.0 % |
2012 |
Sarepta Therapeutics Inc
|
Independent Director |
90.7 K |
11.2 % |
2012 |
Western Midstream Partners LP - Unit
|
Director |
- |
- |
2011 |
Western Midstream Partners LP - Unit
|
Director |
163.0 K |
- |
2011 |
Sarepta Therapeutics Inc
|
Independent Director |
81.6 K |
1.2 % |
2010 |
Sarepta Therapeutics Inc
|
Independent Director |
80.6 K |
- |
2009 |
Sarepta Therapeutics Inc
|
Director |
- |
- |